Answers are grounded in this paper and cite their sources.
Shows FDX2 is essential for initiating tumors but not for their growth in mice, indicating distinct tumor progression mechanics.
Abstract Iron-sulfur (Fe-S) clusters bind to Fe-S proteins and are required for their function and/or structural stability. Recent work reveals an essential role for Fe-S cluster biosynthesis in cancer cell proliferation in vitro, but how Fe-S cluster metabolism contributes to tumor activity in vivo is unclear. Here we report analysis suggesting a stage-specific requirement for FDX2, a critical component of the Fe-S cluster assembly complex, in cancer progression. Using inducible loss-of-function transplant models of a human ovarian cancer line, we show that FDX2 is required for tumor initiation and metastasis but not for growth of established tumors in mice. We report global upregulation of Fe-S proteins under low oxygen conditions and concomitant attenuation of FDX2 loss-mediated disruption of many Fe-S proteins, enabling FDX2-independent proliferation. Our findings highlight a differential requirement of Fe-S cluster biosynthesis for tumor metastasis versus growth and low oxygen-mediated mitigation of Fe-S protein loss promoted by FDX2 deficiency.
No takes yet. Share an insight, caveat, or question.
Hashimoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: